PAJ Inc (Prime Art and Jewel) Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • PAJ Inc (Prime Art and Jewel)'s estimated annual revenue is currently $30.1M per year.(i)
  • PAJ Inc (Prime Art and Jewel)'s estimated revenue per employee is $251,000

Employee Data

  • PAJ Inc (Prime Art and Jewel) has 120 Employees.(i)
  • PAJ Inc (Prime Art and Jewel) grew their employee count by 13% last year.

PAJ Inc (Prime Art and Jewel)'s People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
SVP - Sales, Marketing & Product DevelopmentReveal Email/Phone
3
VP, Product DevelopmentReveal Email/Phone
4
Marketing DirectorReveal Email/Phone
5
Director SalesReveal Email/Phone
6
Director FinanceReveal Email/Phone
7
Associate Art DirectorReveal Email/Phone
8
Ecommerce Marketing ManagerReveal Email/Phone
9
Sales Support ManagerReveal Email/Phone
10
Jewelry Product DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M330%N/AN/A
#2
$2.4M167%N/AN/A
#3
$6.6M330%N/AN/A
#4
$27.4M109-4%N/AN/A
#5
$7.8M398%N/AN/A
#6
$45.6M165-31%N/AN/A
#7
$11.5M51-2%N/AN/A
#8
$3.7M21N/AN/AN/A
#9
$22.1M88-3%N/AN/A
#10
$4.7M27-31%N/AN/A
Add Company

What Is PAJ Inc (Prime Art and Jewel)?

PAJ got its start nearly 40 years ago providing quality bridge jewelry to a growing market. Today, PAJ maintains a global presence, with offices worldwide and more than 3,000 employees including our manufacturing and R&D facilities in China. Our growth is a result of our innovative manufacturing techniques, as well as our commitment to deliver excellent quality, service, and value. Our clients rank among the world's top retailers, and we are very fortunate to have one of the largest customer bases in the industry.

keywords:Fashion,Fitness and Wellness,Healthcare,Pharmaceuticals,Physical Security,Security

N/A

Total Funding

120

Number of Employees

$30.1M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PAJ Inc (Prime Art and Jewel) News

2022-03-22 - Anterior Uveitis Treatment Market 2022-2026 | Increasing ...

AbbVie Inc., Alimera Sciences Inc., Allergan Plc, Bausch Health ... one of the prime reasons driving the anterior uveitis treatment market...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.4M1200%N/A
#2
$25.2M12030%N/A
#3
$300M1209%$32M
#4
$7.5M120N/AN/A
#5
$7.5M1201%N/A